Medtech product approvals drop in Australia

04/17/2013 | Clinica (subscription required)

The number of new medtech products approved in Australia declined throughout the last quarter of 2012 and first quarter of 2013, and the trend is expected to continue if the government sets stricter standards for higher risk products. The Therapeutic Goods Administration has proposed increasing pre-market scrutiny of medical devices and making its decision-making process more transparent, which could lead to delayed approvals.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC